Previous 10 | Next 10 |
ALISO VIEJO, Calif., Feb. 21, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high quality customized vision to patients following cataract surgery, today announced that it will report financial results for the fourth...
ALISO VIEJO, Calif., Feb. 14, 2023 (GLOBE NEWSWIRE) -- RxSight, Inc. (“RxSight ® ”), an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced that, in connection with its previously announced public offer...
RxSight ( NASDAQ: RXST ) priced a common stock offering to raise ~$50M in gross proceeds. The company expects to sell 4M shares at $12.50 apiece. RxSight granted the underwriter a 30-day option to buy up to an additional 600K shares The medical device maker plans to use th...
ALISO VIEJO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc. (“RxSight”), an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, announced today that it has priced its underwritten public off...
RxSight ( NASDAQ: RXST ) on Tuesday announced that it intends to offer and sell $40.0 million of shares of its common stock in an underwritten public offering. RxSight expects to grant the underwriters a 30-day option to purchase up to an additional 15% of the shares of c...
ALISO VIEJO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, announced today that it intends to offer and sell, subject to market and other condi...
Medical technology company RxSight ( NASDAQ: RXST ) expects Q4 revenue of ~$16.1M, representing growth of around 91% Y/Y. Analysts expect the company to generate $14.63M revenue for the quarter . The quarterly revenue growth was driven by the sale of 57 Light Delivery Devices ...
ALISO VIEJO, Calif., Jan. 08, 2023 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced certain preliminary unaudited financial and operational results for the ...
ALISO VIEJO, Calif., Dec. 28, 2022 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) RxSight, Inc., an ophthalmic medical device company dedicated to improving the vision of patients following cataract surgery, today announced plans to participate in the upcoming J.P. Morgan Healthcare Conference. RxS...
RxSight ( NASDAQ: RXST ) is trading ~5% lower after Wells Fargo downgraded to equal weight from overweight Wells Fargo analyst Larry Biegelsen believes demand for RxSight's light adjustable lens (LAL) will be sensitive to a possible economic downturn. The analyst said LAL...
News, Short Squeeze, Breakout and More Instantly...
ALISO VIEJO, Calif., July 22, 2024 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) – RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced that it will report financial results for the second...
ALISO VIEJO, Calif., June 05, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery, today announced plans to participate in the upcoming Truist Securities MedTech Conference. ...
Shareholders approved all agenda items and proposals of the Board of Directors Robert K. Warner, M.B.A. and Arshad M. Khanani, M.D., M.A., FASRS elected as members of the Board of Directors Baruch D. Kuppermann, M.D., Ph.D. and Frank G. Holz, M.D., Ph.D. appointed as members of th...